NDC 70297-003-02 - Capecitabine Tablets, 150 mg
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70297-003
- Requested NDC
- 70297-003-02
- Package NDCs from labels
- 70297-003-02
- Manufacturer
- Prodigy Innovation, LLC.
- Effective date
- 2019-04-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Capecitabine Tablets, USP 150 mg and 500 mg | Prodigy Innovation, LLC. | 2019-04-21 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70297-003-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-58e3-a910-e053-dadaa90a0b85 | Capecitabine Tablets, USP 150 mg and 500 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70297-003-02 | Capecitabine Tablets, 150 mg | 25000 in 1 BAG | TABLET | 25000 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| capecitabine | CAPECITABINE | NorthStar RxLLC | 0b59e98c-5b34-4b93-90f6-20526f4d4f88 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | 200328 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Aurobindo Pharma Limited | 56441153-a1e5-4fdc-96d6-f21baa6b5fbe | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Ascend Laboratories, LLC | 06a88b03-6c06-4dae-b3bc-1e8dd81c9067 | 2026-06-17 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| capecitabine | CAPECITABINE | Camber Pharmaceuticals, Inc. | 3e7d6317-1439-4976-ae00-6f62619ec3dd | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Golden State Medical Supply, Inc. | e28a5ef7-4731-f8ac-e053-2995a90a21bf | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| XELODA | CAPECITABINE | H2-Pharma, LLC | e702d84d-7162-4751-bf37-d724cc7e45a5 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | BluePoint Laboratories | 88c5af84-900a-4372-b056-bfea70c129cf | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Teva Pharmaceuticals USA, Inc. | 5753679a-506c-4ac4-b8b2-b27c664d1d40 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| capecitabine | CAPECITABINE | Dr. Reddy's Laboratories Limited | 007e3432-c8aa-2a76-52ba-c346924c08a7 | 2025-11-20 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Quallent Pharmaceuticals Health LLC | d23f023a-ea62-4ac0-f615-d5d26d59526d | 2025-11-20 | Boxed warning, Warnings, Adverse reactions | 200328 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Lifestar Pharma LLC | 643a31d6-0e30-4602-a9b4-355fe944bfea | 2025-11-03 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | American Health Packaging | 2777b481-7d7f-461a-b5e0-c09ce2990c34 | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | 200328 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | CivicaScript LLC | 4ec2cfc1-e8ca-4109-8b90-1aab07cbab21 | 2025-06-25 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Teyro Labs Private Limited | 0c873e5b-51c2-4685-86c5-53f98563b093 | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Novadoz Pharmaceuticals LLC | 29885ada-b743-419c-8f15-edd4247c76ca | 2024-05-11 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| CAPECITABINE | CAPECITABINE | Accord Healthcare Inc. | 8345d55e-ad02-4726-a04b-1a46e3337a4b | 2024-01-04 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Sun Pharmaceutical Industries, Inc. | e3b1a2b5-f1ce-45ea-afd8-68aac53665fa | 2023-06-06 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine | CAPECITABINE | Cipla USA Inc. | 2871c37d-5e55-437b-a434-fc86d845492a | 2023-06-06 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| CAPECITABINE | CAPECITABINE | BluePoint Laboratories | bbb12406-ce02-3f31-e053-2995a90a0b16 | 2023-05-31 | Boxed warning, Warnings, Adverse reactions | 200328 200327 6804DJ8Z9U |
| Capecitabine 500mg | CAPECITABINE | Armas Pharmaceuticals Inc. | f050d16c-ab76-489d-b92c-8c155b4e3f7c | 2020-12-26 | Boxed warning, Warnings, Adverse reactions | 200328 6804DJ8Z9U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.